Peripheral venous catheter colonization after skin disinfection with 0.5% aqueous sodium hypochlorite, preceded or not by one application of 70% ethanol (DACLEAN): a single-centre, randomized, open-label, pilot study.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 25 06 2021
revised: 16 11 2021
accepted: 16 11 2021
pubmed: 26 11 2021
medline: 16 2 2022
entrez: 25 11 2021
Statut: ppublish

Résumé

Few data are available on the efficacy of 0.5% aqueous sodium hypochlorite (SH) for skin disinfection before peripheral catheter insertion. A total of 239 patients were randomly assigned to either one application of SH alone or one application of SH preceded by one application of 70% ethanol (ET-SH). Catheter colonization, defined as a catheter tip culture growing >1000 cfu of a micro-organism per millilitre, occurred in 29 patients (33% of 89 colonizations per 1000 catheter-days) in the SH group and in 31 patients (33% of 126 colonizations per 1000 catheter-days) in the ET-SH group.

Identifiants

pubmed: 34822950
pii: S0195-6701(21)00410-2
doi: 10.1016/j.jhin.2021.11.012
pii:
doi:

Substances chimiques

Anti-Infective Agents, Local 0
Ethanol 3K9958V90M
Sodium Hypochlorite DY38VHM5OD

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-126

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

B Drugeon (B)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France.

M Pichon (M)

CHU de Poitiers, Département des agents infectieux, Laboratoire de Bactériologie-Hygiène, Poitiers, France; Université de Poitiers, INSERM U1070, Pharmacologie des Agents Anti-Infectieux et Résistance (PHAR2), Poitiers, France.

N Marjanovic (N)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France.

S Mousse (S)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France.

S Seguin (S)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France.

C Raynaud (C)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France; Université de Poitiers, UFR de Médecine-Pharmacie, Poitiers, France.

A Rahoui (A)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France; Université de Poitiers, UFR de Médecine-Pharmacie, Poitiers, France.

D Frasca (D)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France; Université de Nantes, INSERM U1246, Methods in Patient-centered Outcomes and Health Research - SPHERE, Nantes, France.

O Mimoz (O)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France; Université de Poitiers, INSERM U1070, Pharmacologie des Agents Anti-Infectieux et Résistance (PHAR2), Poitiers, France; Université de Poitiers, UFR de Médecine-Pharmacie, Poitiers, France. Electronic address: Olivier.MIMOZ@chu-poitiers.fr.

J Guenezan (J)

CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH